New pharmacotherapies and novel approaches, such as gene therapy and cell therapy, are raising realistic hopes for patients with geographic atrophy, a condition that can lead to vision loss.
“There has been a tremendous amount of clinical research looking at different therapeutic avenues for geographic atrophy, and we have had some prominent disappointments over the last 10 years. But recently we had some very promising successes that bring a lot of hope and encouragement to a field that is continuing to drive innovation,” Charles C. Wykoff, MD, PhD, said.
Geographic atrophy (GA) is